Check Out What Whales Are Doing With ABBV
Portfolio Pulse from Benzinga Insights
A significant bullish stance has been taken on AbbVie (NYSE:ABBV) by a large investor or institution, as indicated by a large position in the company's options. The sentiment among these big-money traders is split 50% bullish and 50% bearish. The price target range for AbbVie over the last 3 months, based on Volume and Open Interest, is $135.0 to $165.0. Barclays has upgraded its action to Overweight with a price target of $170, while Morgan Stanley maintains their Overweight rating with a price target of $193 and $196.
November 03, 2023 | 6:15 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
A large investor has taken a bullish stance on AbbVie, with a split sentiment among big-money traders. Analysts from Barclays and Morgan Stanley have given positive ratings and high price targets.
The news of a large investor taking a bullish stance on AbbVie, along with positive ratings and high price targets from Barclays and Morgan Stanley, indicates a positive short-term impact on the company's stock. The split sentiment among big-money traders suggests some uncertainty, but the overall outlook appears positive.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100